A Phase I Study of ZD6474 (Zactima) Alone and in Combination with Retinoic Acid in Relapsed and Refractory Pediatric Neuroblastoma and Medulloblastoma.
Phase of Trial: Phase I
Latest Information Update: 14 Dec 2011
At a glance
- Drugs Tretinoin; Vandetanib
- Indications Medulloblastoma; Neuroblastoma
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 14 Nov 2011 Actual patient number is 10 according to ClinicalTrials.gov.
- 14 Nov 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.